Goldman Sachs
PASG icon

Goldman Sachs’s Passage Bio PASG Stock Holding History

Goldman Sachs’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-580
Closed -$4.64K – 6572
2025
Q2 		$4.64K Hold
580
– – ﹤0.01% 6022
2025
Q1 		$4.09K Sell
580
-773
-57% -$8.36K ﹤0.01% 5993
2024
Q4 		$15.3K Sell
1,353
-1
-0.1% -$13 ﹤0.01% 5918
2024
Q3 		$18.9K Sell
1,354
-8
-0.6% -$127 ﹤0.01% 5678
2024
Q2 		$21.6K Buy
1,362
+14
+1% +$343 ﹤0.01% 5513
2024
Q1 		$36.4K Buy
1,348
+3
+0.2% +$72 ﹤0.01% 5347
2023
Q4 		$27.2K Sell
1,345
-27
-2% -$373 ﹤0.01% 5430
2023
Q3 		$18.1K Sell
1,372
-4
-0.3% -$66 ﹤0.01% 5367
2023
Q2 		$25.9K Hold
1,376
– – ﹤0.01% 5524
2023
Q1 		$26.4K Sell
1,376
-59
-4% -$1.6K ﹤0.01% 5642
2022
Q4 		$39.6K Sell
1,435
-1,857
-56% -$46.9K ﹤0.01% 5625
2022
Q3 		$82K Sell
3,292
-1,824
-36% -$71.9K ﹤0.01% 5731
2022
Q2 		$242K Sell
5,116
-2,261
-31% -$106K ﹤0.01% 5545
2022
Q1 		$458K Buy
7,377
+490
+7% +$40.4K ﹤0.01% 5371
2021
Q4 		$875K Buy
6,887
+873
+15% +$143K ﹤0.01% 4962
2021
Q3 		$1.2M Buy
6,014
+1,248
+26% +$298K ﹤0.01% 4607
2021
Q2 		$1.26M Buy
4,766
+945
+25% +$292K ﹤0.01% 4589
2021
Q1 		$1.34M Sell
3,821
-1,007
-21% -$430K ﹤0.01% 4381
2020
Q4 		$2.47M Buy
4,828
+4,094
+558% +$1.64M ﹤0.01% 3571
2020
Q3 		$192K Buy
+734
New +$253K ﹤0.01% 4928
2020
Q2 		– Sell
-6,160
Closed -$1.94M – 5406
2020
Q1 		$1.94M Buy
+6,160
New +$1.93M ﹤0.01% 3330

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's PASG Position: Q3 2025 in Review

Goldman Sachs sold out of Passage Bio (PASG) in Q3 2025, closing a stake of 580 shares — an estimated $4.64K sold.

Goldman Sachs first reported a position in PASG in Q1 2020 and held it in 21 quarters. The position peaked at $2.47M in Q4 2020. 32 funds tracked by Wall St. Rank hold PASG as of Q3 2025.

  • Goldman Sachs reported no remaining Passage Bio position as of Q3 2025 after selling out during the quarter.
  • Goldman Sachs sold 580 Passage Bio shares in Q3 2025, an estimated $4.64K.
  • Goldman Sachs first reported a position in Passage Bio in Q1 2020 and held it in 21 quarters.
  • Goldman Sachs's Passage Bio position peaked at $2.47M in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Passage Bio as of Q3 2025.

Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.